| Detected | Trial | Change |
|---|---|---|
| 2026-05-16 | NCT07335562 A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel /… |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-22 | NCT07603557 Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE) | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07335562 | A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel /… | Systemic Sclerosis | Recruiting |
| Phase 2 | |||
| NCT07015983 | A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in… | Lupus Erythematosus, Systemic | Recruiting |
| NCT07603557 | Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE) | Chronic Immune Thrombocytopenia | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07388277 | CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis | Antineutrophil Cytoplasmic Antibody-associated Vasculitis | Recruiting |
| Phase 1 | |||
| NCT06220201 | A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in… | Multiple Sclerosis | Recruiting |
| NCT05869955 | A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe… | Systemic Lupus Erythematosus | Recruiting |
| NCT07573332 | A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody… | AQP4+ NMOSD | Not Yet Recruiting |